Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10041494 | 1.00 | LMNA (0.62) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL22015868 | 1.00 | LMNA (0.62) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL14047287 | 1.00 | LMNA (0.62) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL13590014 | 1.00 | LMNA (0.62) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL12424295 | 0.95 | LMNA (0.62) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL28735641 | 0.93 | LMNA (0.59) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL28735640 | 0.93 | LMNA (0.59) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL28735642 | 0.93 | LMNA (0.59) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL26643162 | 0.92 | LMNA (0.48) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL16174558 | 0.86 | LMNA (0.64) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114502604-A | Process for polymerizing polypropylene using ziegler-natta procatalyst with novel 1, 3-diether internal electron donor | SABIC环球技术有限责任公司 | 2022-05-13 | — | — | CN | claimed |
| CN-110023351-B | Main catalyst composition prepared by combining internal electron donors | 格雷斯公司 | 2022-04-26 | — | — | CN | claimed |
| CN-118251425-A | Catalyst component for propylene polymerization with improved catalyst performance | 格雷斯公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-116096810-A | Phthalate-free polypropylene homopolymers with high stiffness properties | 格雷斯公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-116096549-A | Oxidative decomposition-resistant polymer compositions and articles made therefrom | 格雷斯公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-115867395-A | Method for producing Mg-containing particles | 东邦钛株式会社 | 2023-03-28 | — | — | CN | disclosed |
| CN-115461380-A | Ziegler-natta (pro-) catalyst systems prepared with nitrogen heterocycles | 陶氏环球技术有限责任公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-114599687-A | Ziegler-natta catalyst for olefin polymerization | 北欧化工公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114502604-A | Process for polymerizing polypropylene using ziegler-natta procatalyst with novel 1, 3-diether internal electron donor | SABIC环球技术有限责任公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-110023351-B | Main catalyst composition prepared by combining internal electron donors | 格雷斯公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114276221-A | Preparation method of alkyl-substituted diether electron donor | 山东研峰新材料科技有限公司 | 2022-04-05 | — | — | CN | disclosed |
| US-20110152491-A1 | NOVEL POLYMERS | BASF SE (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20110152491-A1 | NOVEL POLYMERS | BASF SE (DE) | 2011-06-23 | — | — | US | disclosed |
| EP-1074600-B1 | Polymeric fluorescent substance and polymer light emitting device | SUMITOMO CHEMICAL CO (JP) | 2009-06-03 | — | — | EP | disclosed |
| EP-0962445-B1 | Acetylene compound, liquid crystal composition and liquid crystal element | MITSUI CHEMICALS INC (JP) | 2003-02-26 | — | — | EP | disclosed |
| EP-0751133-B1 | Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same | MITSUI CHEMICALS INC (JP) | 2001-09-12 | — | — | EP | disclosed |
| US-6217793-B1 | Acetylene compound, liquid crystal composition and liquid crystal element | MITSUI CHEMICALS, INC. (JP) | 2001-04-17 | — | — | US | disclosed |
| EP-0962445-A1 | Acetylene compound, liquid crystal composition and liquid crystal element | Mitsui Chemicals, Inc. (JP) | 1999-12-08 | — | — | EP | disclosed |
| US-5770108-A | HIGH SPEED RESPONSE, MOLECULAR ORIENTATION, HIGH CONTRAST, RECEPTIVITY | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0751133-A1 | Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152491-A1 | NOVEL POLYMERS | PLEC, PUF60, VIM | LMNA 2973/4885BLM 98/4885PTPN1 4026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.